Initial prescription of antipsychotics and antidepressants in general practice and specialist care in Norway

Acta Psychiatrica Scandinavica

Volumn 123, Issue 6, 2011, Pages 459-465

  Kjosavik, S R ^a,b   Hunskaar, S ^a   Aarsland, D ^a,c   Ruths, S ^a,b  

^a UNIVERSITY OF BERGEN   (Norway)

^b Research Unit for General Practice   (Norway)

^c STAVANGER UNIVERSITY HOSPITAL   (Norway)

Author keywords

Antidepressants; Antipsychotics; General practitioners; Incidence; Psychiatrists

Indexed keywords

AMISULPRIDE; AMITRIPTYLINE; ANTIDEPRESSANT AGENT; ARIPIPRAZOLE; CHLORPROMAZINE; CHLORPROTHIXENE; CITALOPRAM; CLOMIPRAMINE; CLOZAPINE; DIXYRAZINE; DOXEPIN; ESCITALOPRAM; FLUOXETINE; FLUPENTIXOL; FLUVOXAMINE; HALOPERIDOL; LEVOMEPROMAZINE; MIANSERIN; NEUROLEPTIC AGENT; NORTRIPTYLINE; OLANZAPINE; PAROXETINE; PERPHENAZINE; QUETIAPINE; RISPERIDONE; SERTINDOLE; TRIMIPRAMINE; UNINDEXED DRUG; ZIPRASIDONE; ZUCLOPENTHIXOL;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DATA BASE; DEPRESSION; DRUG USE; FEMALE; GENERAL PRACTICE; GENERAL PRACTITIONER; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MEDICAL SPECIALIST; NORMAL HUMAN; NORWAY; PATIENT CARE; PRESCRIPTION; PRIORITY JOURNAL; PROFESSIONAL PRACTICE; PSYCHIATRIST; PSYCHOSIS;

ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; ANTIDEPRESSIVE AGENTS; ANTIPSYCHOTIC AGENTS; CROSS-SECTIONAL STUDIES; DRUG UTILIZATION; FEMALE; GENERAL PRACTICE; HUMANS; MALE; MENTAL DISORDERS; MIDDLE AGED; NORWAY; PSYCHIATRY; SEX DISTRIBUTION; YOUNG ADULT;

EID: 79955958362     PISSN: 0001690X     EISSN: 16000447     Source Type: Journal    
DOI: 10.1111/j.1600-0447.2011.01697.x     Document Type: Article

References (27)

1. Verdoux H, Tournier M, Begaud B. Antipsychotic prescribing trends: a review of pharmaco-epidemiological studies. Acta Psychiatr Scand 2010;121:4-10.
2. Moore M, Yuen HM, Dunn N, Mullee MA, Maskell J, Kendrick T. Explaining the rise in antidepressant prescribing: a descriptive study using the general practice research database. BMJ 2009;339:b4361.
3. Raymond CB, Morgan SG, Caetano PA. Antidepressant utilization in British Columbia from 1996 to 2004: increasing prevalence but not incidence. Psychiatr Serv 2007;58:79-84.
4. Guaiana G, Andretta M, Corbari L et al. Antidepressant drug consumption and public health indicators in Italy, 1955 to 2000. J Clin Psychiatry 2005;66:750-755.
5. Olfson M, Marcus SC. National patterns in antidepressant medication treatment. Arch Gen Psychiatry 2009;66:848-856.
6. Bramness JG, Hausken AM, Sakshaug S, Skurtveit S, Ronning M. [Prescription of selective serotonin reuptake inhibitors 1990-2004]. Tidsskr Nor Laegeforen 2005;125:2470-2473.
7. St.prp. nr. 63 (1997) Opptrappingsplanen for psykisk helse 1999-2006. The Ministry of Health and Care Services 1998 [updated 1998; cited 2010 06.09.]; Available from:
8. Nielsen J, Le Quach P, Emborg C, Foldager L, Correll CU. 10-year trends in the treatment and outcomes of patients with first-episode schizophrenia. Acta Psychiatr Scand 2010;122:356-366.
9. Kaye JA, Bradbury BD, Jick H. Changes in antipsychotic drug prescribing by general practitioners in the United Kingdom from 1991 to 2000: a population-based observational study. Br J Clin Pharmacol 2003;56:569-575.
10. Patten SB, Esposito E, Carter B. Reasons for antidepressant prescriptions in Canada. Pharmacoepidemiol Drug Saf 2007;16:746-752.
11. Gardarsdottir H, Heerdink ER, Van Dijk L, Egberts AC. Indications for antidepressant drug prescribing in general practice in the Netherlands. J Affect Disord 2007;98:109-115.
12. Kjosavik SR, Ruths S, Hunskaar S. Psychotropic drug use in the Norwegian general population in 2005: data from the Norwegian Prescription Database. Pharmacoepidemiol Drug Saf 2009;18:572-578.
13. The Norwegian Prescription Database The Norwegian Institute of Public Health 2009 [updated 2009; cited 2010 12.04.]; Available from:
14. ATC/DDD Index 2010. Who Collaborating Centr for Drug Statistics Metodology; 2010 [updated 2010; cited 2010 12.04.]; Available from:
15. Norwegian Social Science Data Services 2010. Data from the Regular GP Scheme, Individual Level Data. [updated 2010; cited 2010 12.04.]; Available from:
16. StatBank Norway. Statistics Norway; 2010 [updated 2010; cited 2010 12.04.]; Available from:
17. Mirandola M, Andretta M, Corbari L, Sorio A, Nose M, Barbui C. Prevalence, incidence and persistence of antipsychotic drug prescribing in the Italian general population: retrospective database analysis, 1999-2002. Pharmacoepidemiol Drug Saf 2006;15:412-420.
18. Trifiro G, Spina E, Brignoli O, Sessa E, Caputi AP, Mazzaglia G. Antipsychotic prescribing pattern among Italian general practitioners: a population-based study during the years 1999-2002. Eur J Clin Pharmacol 2005;61:47-53.
19. Trifiro G, Barbui C, Spina E et al. Antidepressant drugs: prevalence, incidence and indication of use in general practice of Southern Italy during the years 2003-2004. Pharmacoepidemiol Drug Saf 2007;16:552-559.
20. Olfson M, Klerman GL. Trends in the prescription of psychotropic medications. The role of physician specialty. Med Care 1993;31:559-564.
21. Pincus HA, Tanielian TL, Marcus SC et al. Prescribing trends in psychotropic medications: primary care, psychiatry, and other medical specialties. JAMA 1998;279:526-531.
22. Mcmanus P, Mant A, Mitchell P, Britt H, Dudley J. Use of antidepressants by general practitioners and psychiatrists in Australia. Aust N Z J Psychiatry 2003;37:184-189.
23. Strom BL, Kimmel SE. Textbook of pharmacoepidemiology. Chichester, West Sussex; Hoboken, NJ: John Wiley & Sons, 2006.
24. Kales HC, Valenstein M, Kim HM et al. Mortality risk in patients with dementia treated with antipsychotics versus other psychiatric medications. Am J Psychiatry 2007;164:1568-1576.
25. Hansen DG, Vach W, Rosholm JU, Sondergaard J, Gram LF, Kragstrup J. Early discontinuation of antidepressants in general practice: association with patient and prescriber characteristics. Fam Pract 2004;21:623-629.
26. Selbaek G, Kirkevold O, Engedal K. The prevalence of psychiatric symptoms and behavioural disturbances and the use of psychotropic drugs in Norwegian nursing homes. Int J Geriatr Psychiatry 2007;22:843-849.
27. Correll CU, Nielsen J. Antipsychotic-associated all-cause and cardiac mortality: what should we worry about and how should the risk be assessed? Acta Psychiatr Scand 2010;122:341-344.